Jump Financial LLC purchased a new stake in shares of Mativ Holdings, Inc. (NYSE:MATV - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 143,629 shares of the company's stock, valued at approximately $895,000. Jump Financial LLC owned about 0.26% of Mativ as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently modified their holdings of the company. D. E. Shaw & Co. Inc. increased its holdings in shares of Mativ by 85.9% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 504,422 shares of the company's stock valued at $5,498,000 after purchasing an additional 233,125 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in shares of Mativ by 5.6% during the first quarter. Allspring Global Investments Holdings LLC now owns 4,131,328 shares of the company's stock worth $25,986,000 after purchasing an additional 217,691 shares during the period. Nuveen LLC acquired a new stake in shares of Mativ in the first quarter valued at approximately $1,121,000. XTX Topco Ltd bought a new stake in shares of Mativ in the first quarter valued at approximately $1,073,000. Finally, Tudor Investment Corp ET AL acquired a new stake in Mativ during the fourth quarter worth approximately $1,864,000. 94.95% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts recently issued reports on MATV shares. Wall Street Zen upgraded shares of Mativ from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Zacks Research upgraded Mativ to a "strong-buy" rating in a research note on Monday, August 11th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Strong Buy" and an average target price of $10.00.
Get Our Latest Research Report on Mativ
Mativ Trading Down 1.6%
MATV traded down $0.20 during midday trading on Thursday, hitting $11.98. 154,378 shares of the company were exchanged, compared to its average volume of 792,781. The firm has a market capitalization of $654.95 million, a P/E ratio of -1.44 and a beta of 0.83. Mativ Holdings, Inc. has a 1-year low of $4.34 and a 1-year high of $19.96. The company has a quick ratio of 1.21, a current ratio of 2.37 and a debt-to-equity ratio of 2.65. The firm's 50 day moving average price is $8.93 and its 200-day moving average price is $7.04.
Mativ (NYSE:MATV - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.15. Mativ had a positive return on equity of 4.12% and a negative net margin of 23.09%.The business had revenue of $525.40 million for the quarter, compared to analyst estimates of $505.00 million. As a group, equities analysts forecast that Mativ Holdings, Inc. will post 1.15 EPS for the current fiscal year.
Mativ Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, September 26th. Stockholders of record on Friday, August 29th will be paid a $0.10 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.40 annualized dividend and a dividend yield of 3.3%. Mativ's dividend payout ratio is presently -4.79%.
Mativ Company Profile
(
Free Report)
Mativ Holdings, Inc, together with its subsidiaries, manufactures and sells specialty materials in the United States, Europe, the Asia Pacific, the Americas, and internationally. The company operates through two segments, Advanced Technical Materials and Fiber-Based Solutions. The Advanced Technical Materials manufactures and sells various engineered polymer, resin and fiber-based substrates, nets, films, adhesive tapes, and other nonwovens for the filtration, protective solutions, release liners, and healthcare end-markets.
Read More

Before you consider Mativ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mativ wasn't on the list.
While Mativ currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.